Streetbeat News

Equity Actions

VTAK

Catheter Precision, Inc. (NYSE:VTAK) announced a definitive agreement for the immediate exercise of certain outstanding warrants, resulting in $4.9 million in gross proceeds. The company will issue new Series K warrants, pending shareholder approval.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:36 pm

ALGN

Align Technology shares rose following the announcement of a $275 million stock buyback as part of its $1 billion repurchase program.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:32 pm

ALGN

Align Technology, Inc. plans to repurchase $275 million of its common stock as part of its $1 billion stock repurchase program approved in January 2023.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:31 pm

HDSN

Hudson Technologies has increased its stock buyback program from $10 million to $20 million, indicating confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:31 pm

ENGN

EnGene Holdings shares rose after the company announced it raised approximately $60 million through a private placement.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:19 pm

ACST

Acasti Pharma has rebranded as Grace Therapeutics, Inc. and will begin trading under the new ticker symbol 'GRCE' on Nasdaq starting October 28, 2024. A virtual key opinion leader event is scheduled for November 20.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:05 pm

SENS

Senseonics Holdings, Inc. has announced a $16 million registered direct offering, involving the purchase and sale of 45,714,286 shares at $0.35 per share.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 12:03 pm

JOBY

Joby Aviation's stock is experiencing a decline following the announcement of a $202 million public offering, with 40 million shares priced at $5.05 each.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 11:59 am

ADC

Agree Realty has priced an upsized public offering of 4.4 million common shares at $74 per share. The company has entered into forward sale agreements with Citibank and Wells Fargo for these shares, with the potential to increase to 5.06 million shares if underwriters exercise their option.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 6:35 am

SEPN

Septerna has priced its upsized IPO at $18 per share, raising $288 million from 16 million common shares. The offering is expected to close on October 28, 2024, pending customary conditions.

Portfolio Pulse from Benzinga Newsdesk

October 25, 2024 | 6:31 am